🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Using gefitinib or Osimertinib, an EGFR tyrosine kinase inhibitor (TKI), in...
Status
Recruiting
Location
The Catholic University of Korea, St. Vincent's Hospital
Start Date
2023-09-05
Trial ID
NCT06156527
Treatments Being Tested
This study is an open-label, dose-escalation and expansion, Phase I clinica...
Status
Active Not Recruiting
Location
St Vincent's Hospital Sydney
Start Date
2024-10-23
Trial ID
NCT06571422
Treatments Being Tested
This is an open-label, multi-center Phase II study of fluzoparib combined w...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2023-10-18
Trial ID
NCT06063070
Treatments Being Tested
One of the most frequent complications of diabetic retinopathy is diabetic ...
Status
Completed
Location
JiWon Lim
Start Date
2009-03
Trial ID
NCT01342159
Treatments Being Tested
This is a randomized, controlled, double-blind, placebo-controlled trial of...
Status
Completed
Location
Stanford University Department of Otolaryngology- Head and Neck Surgery
Start Date
2014-08-04
Trial ID
NCT02389959
Treatments Being Tested
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
A randomized, controlled, multicenter clinical study of SHR-A1811 combined ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-30
Trial ID
NCT07355764
Treatments Being Tested
Phase II study: a study to explore the safety and preliminary efficacy of B...
Status
Recruiting
Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Start Date
2023-12-13
Trial ID
NCT06123884
This study is a single-arm, single-center, non-randomized, open-label study...
Status
Unknown
Location
AnhuiI Provincial Hospital
Start Date
2023-12-19
Trial ID
NCT06590844
Treatments Being Tested
Observe the safety and tolerability of the single and multiple doses of 601...
Status
Unknown
Location
Chinese PLA General Hospital of Central Theater.
Start Date
2019-03-08
Trial ID
NCT04151407
Treatments Being Tested